Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype.

MLA

Singer, C. F., et al. “Coexpression of Stromelysin-3 and Insulin-like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype.” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, June 1997, pp. 1917–22. EBSCOhost, https://doi.org/10.1210/jcem.82.6.4023.

APA

Singer, C. F., Rasmussen, A., Lippman, M. E., & Cullen, K. J. (1997). Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype. The Journal of Clinical Endocrinology and Metabolism, 82(6), 1917–1922. https://doi.org/10.1210/jcem.82.6.4023

Chicago

Singer, C F, A Rasmussen, M E Lippman, and K J Cullen. 1997. “Coexpression of Stromelysin-3 and Insulin-like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype.” The Journal of Clinical Endocrinology and Metabolism 82 (6): 1917–22. doi:10.1210/jcem.82.6.4023.